Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carroll

Showing results (1321-1330 of 1,434) with videos related to

Pageof 144
Sort By:
JAMA|September 22, 2011
Prediction of erectile function following treatment for prostate cancerMehrdad Alemozaffar, Meredith M Regan, Matthew R Cooperberg, et al.
The Lancet. Oncology|October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysisShuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
Scientific Reports|January 4, 2024
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarkerShiqin Liu, Sarah J Hawley, Christian A Kunder, et al.
JAMA Oncology|March 29, 2019
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialWolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2023
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panelAnne-Claire Berrens, Matthijs Scheltema, Tobias Maurer, et al.
BMC Cancer|December 5, 2023
Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative studyAlice Guan, Eduardo J Santiago-Rodríguez, Benjamin I Chung, et al.
Journal of the National Cancer Institute|October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic TargetShuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
The American Journal of Surgical Pathology|September 17, 2016
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective CohortJesse K McKenney, Wei Wei, Sarah Hawley, et al.
Cell Reports|April 8, 2014
Antagonism of tumoral prolactin receptor promotes autophagy-related cell deathYunfei Wen, Behrouz Zand, Bulent Ozpolat, et al.
Critical Reviews in Oncology/Hematology|August 11, 2012
Active surveillance for low-risk prostate cancerChris H Bangma, Meelan Bul, Theo H van der Kwast, et al.
Pageof 144

Showing results (1321-1330 of 1,434) with videos related to

Sort By:
Pageof 144
JAMA|September 22, 2011
Prediction of erectile function following treatment for prostate cancerMehrdad Alemozaffar, Meredith M Regan, Matthew R Cooperberg, et al.
The Lancet. Oncology|October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysisShuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
Scientific Reports|January 4, 2024
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarkerShiqin Liu, Sarah J Hawley, Christian A Kunder, et al.
JAMA Oncology|March 29, 2019
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialWolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2023
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panelAnne-Claire Berrens, Matthijs Scheltema, Tobias Maurer, et al.
BMC Cancer|December 5, 2023
Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative studyAlice Guan, Eduardo J Santiago-Rodríguez, Benjamin I Chung, et al.
Journal of the National Cancer Institute|October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic TargetShuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
The American Journal of Surgical Pathology|September 17, 2016
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective CohortJesse K McKenney, Wei Wei, Sarah Hawley, et al.
Cell Reports|April 8, 2014
Antagonism of tumoral prolactin receptor promotes autophagy-related cell deathYunfei Wen, Behrouz Zand, Bulent Ozpolat, et al.
Critical Reviews in Oncology/Hematology|August 11, 2012
Active surveillance for low-risk prostate cancerChris H Bangma, Meelan Bul, Theo H van der Kwast, et al.
Pageof 144